Upregulation of the AKT-mTOR signaling pathway in platinum-resistant tumor cells has been documented and targeting mTORC1/2 has been shown to reverse platinum resistance in tumors, guiding the direction of our investigation [53]. This evidence concerns the gene AKT1 and neoplasm.